Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Newcastle Clonado Plus
- Development stage
- Unknown
- Lead developer
- FARVET
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Ocular, Intranasal, Oral, Inhalation
01
Overview
Newcastle Clonado Plus is a live attenuated lyophilized vaccine developed by FARVET for the immunization of poultry against Newcastle Disease. It contains a cloned selection of the LaSota strain of the Newcastle Disease Virus (NDV). The LaSota strain is a lentogenic (mild) virus that effectively stimulates the immune system to produce protective antibodies with minimal adverse reactions. The "Clonado" designation indicates that the virus strain has been specifically selected and cloned for stability and consistent immunogenicity. This vaccine is typically administered via ocular, intranasal, or drinking water routes, or by coarse spray, to provide broad protection across poultry flocks by inducing both mucosal and systemic immunity.
- Brand names
- Newcastle Clonado Plus
- Other names
- Newcastle Clonado Plus-FARVETNewcastle Disease Virus (NDV) LaSota strain vaccine
Beyond the preview
Go deeper on Newcastle Clonado Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Newcastle Clonado Plus.